WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 44'5801 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 45'1921 Child (under 5 years) mortality rate: 22

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 5'523  5'503  5'482  5'460  5'437  5'188  4'996  4'788 
Births 60  59  59  59  59  58  64  65 
Surviving infants 60  59  59  59  59  57  64  64 
Pop. less than 5 years 297  297  300  301  303  295  311  321 
Pop. less than 15 years 906  901  899  894  891  941  965  972 
Female 15-49 years 1'144  1'148  1'151  1'155  1'160  1'220  1'260  1'220 

Number of reported cases

(Click for retrospective incidence data for Finland)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  11  2'147 
Mumps
ChartChart
  10 
Pertussis
ChartChart
  399  432  165  192  707  187 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Finland)
Vaccine year result method % card seen                                                
BCG          99  91 
DTP1          99  99 
DTP3          89  92  97  98  99  90 
DTP4          85 
IPV1          99  99 
HepB_BD         
HepB3         
Hib3          89  92  97  98 
JapEnc         
MCV1          94  95  95  97  96  97 
MCV2          92  85 
MenA         
PCV1          96  95 
PCV2          94  94 
PCV3          85  87  92 
Pol3          89  92  97  98  95  90 
Rota1          93  93  94 
RotaC          80  84  91  93 
RCV1          94  95  95  97 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Finland)
BCG
ChartChart
  99  91  90 
DTP1
ChartChart
  98  99  99  99  99  99  96  97 
DTP3
ChartChart
  89  92  97  98  98  99  90  92 
HepB3
 
HepB_BD
 
Hib3
ChartChart
  89  92  97  98  98  96 
MCV1
ChartChart
  94  94  95  96  97  96  97 
MCV2
ChartChart
  92  85 
PCV3
ChartChart
  85  87  92  92  92 
Pol3
  89  92  97  98  98  96  90  90 
RCV1
ChartChart
  94  94  95  96  97  96  97 
RotaC
ChartChart
  80  84  91  92  93 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG <7 years; Yes if parents from a high TB incidence country
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 4 years; Yes
HepA_Adult Yes medical at risk; MSM
HepA_Pediatric Yes medical risk groups
HepB_Adult Yes medical risk groups
HepB_Pediatric Yes medical risk groups
HPV Y11-Y12; Yes females only
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers, other risk groups
Influenza_Pediatric 6 months-3 years; Yes and children with chronic illness
IPV Yes persons arriving from or departing for at-risk areas (staying at least 4 weeks)
MMR 12-18 months; 6 years; Yes 2nd dose at any age if not previously administered
Pneumo_conj 3, 5, 12 months; Yes
Rotavirus 2, 3, 5 months; Yes
Td Yes booster every 10 years for adults
Varicella 18 months, 6 years; Yes catch up dose children 1Y and 5-11 years who have not had chickenpox

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  NA    No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number   300           
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No    No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     100         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.